MONO PHARMACARE LIMITED DCF Valuation
MONOPHARMA · Healthcare · Current price ₹8.55
MONO PHARMACARE LIMITED intrinsic-value estimate
Our intrinsic-value model estimates MONO PHARMACARE LIMITED is worth ₹17 per share, based on 10% ROE fading to 14% over ~3 yrs, on ₹18 book. Rather than a raw DCF — which is highly sensitive to fragile cash-flow forecasts — we use a residual-income (excess-return) model: a company is worth its book value plus the present value of the returns it earns ABOVE its cost of equity. A none economic moat sets how long that edge is assumed to last.
Try your own assumptions
Prefer a classic discounted-cash-flow view? Open the DCF calculator below — it pre-fills MONO PHARMACARE LIMITED's real free cash flow, net debt and share count so you can model your own growth and discount-rate scenario in seconds.
More on MONO PHARMACARE LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.